ROXI-ASPEN - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A PHASE 3, MULTICENTER, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE REGN7508, A FACTOR XI MONOCLONAL ANTIBODY, VERSUS ACETYLSALICYLIC ACID FOR PROPHYLAXIS OF SYMPTOMATIC VENOUS THROMBOEMBOLISM AFTER ELECTIVE TOTAL KNEE ARTHROPLASTY (ROXI-ASPEN)
Principal Investigator
Thorsten M. Seyler, MD, PhD
Joint Replacement Surgeon
Protocol Number
IRB:
PRO00119643
NCT:
NCT07213778
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment